Pourcher, V., Gourmelen, J., Bureau, I. & Bouee, S. Comorbidities in people living with HIV: an epidemiologic and economic analysis using a claims database in France. PLoS ONE 15, e0243529 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galvez, C. et al. Atlas of the HIV-1 reservoir in peripheral CD4 T cells of individuals on successful antiretroviral therapy. mBio. 12, e0307821 (2021).

Article  PubMed  Google Scholar 

Chomont, N. et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15, 893–900 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salantes, D. B. et al. HIV-1 latent reservoir size and diversity are stable following brief treatment interruption. J. Clin. Invest. 128, 3102–3115 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Tian, Y., Mollo, S. B., Harrington, L. E. & Zajac, A. J. IL-10 regulates memory T cell development and the balance between Th1 and follicular Th cell responses during an acute viral infection. J. Immunol. 197, 1308–1321 (2016).

Article  CAS  PubMed  Google Scholar 

Santos, C. O. et al. Blocking IL-10 signaling with soluble IL-10 receptor restores in vitro specific lymphoproliferative response in dogs with leishmaniasis caused by Leishmania infantum. PLoS ONE 16, e0239171 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rojas, J. M., Avia, M., Martin, V. & Sevilla, N. IL-10: a multifunctional cytokine in viral infections. J. Immunol. Res. 2017, 6104054 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Jones, M. et al. IL-10 restricts memory T cell inflation during cytomegalovirus infection. J. Immunol. 185, 3583–3592 (2010).

Article  CAS  PubMed  Google Scholar 

Kulpa, D. A. et al. Differentiation into an effector memory phenotype potentiates HIV-1 latency reversal in CD4(+) T cells. J. Virol. 93, e00969–19 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pitt, J. M. et al. Blockade of IL-10 signaling during bacillus Calmette-Guerin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-gamma and IL-17 responses and increases protection to Mycobacterium tuberculosis infection. J. Immunol. 189, 4079–4087 (2012).

Article  CAS  PubMed  Google Scholar 

Ejrnaes, M. et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203, 2461–2472 (2006).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brockman, M. A. et al. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 114, 346–356 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saeidi, A. et al. T-cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune responses. Front. Immunol. 9, 2569 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Wilson, E. B. & Brooks, D. G. The role of IL-10 in regulating immunity to persistent viral infections. Curr. Top. Microbiol Immunol. 350, 39–65 (2011).

CAS  PubMed  PubMed Central  Google Scholar 

Rigopoulou, E. I., Abbott, W. G., Haigh, P. & Naoumov, N. V. Blocking of interleukin-10 receptor–a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus. Clin. Immunol. 117, 57–64 (2005).

Article  CAS  PubMed  Google Scholar 

Harper, J. et al. Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy. J. Clin. Invest. 132, e155251 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fromentin, R. et al. CD4+ T cells expressing PD-1, TIGIT and LAG-3 contribute to HIV persistence during ART. PLoS Pathog. 12, e1005761 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Trautmann, L. et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12, 1198–1202 (2006).

Article  CAS  PubMed  Google Scholar 

Chikuma, S. et al. PD-1-mediated suppression of IL-2 production induces CD8+ T cell anergy in vivo. J. Immunol. 182, 6682–6689 (2009).

Article  CAS  PubMed  Google Scholar 

Li, J. et al. Reversal of the CD8(+) T-cell exhaustion induced by chronic HIV-1 infection through combined blockade of the adenosine and PD-1 pathways. Front. Immunol. 12, 687296 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Breton, G. et al. Programmed death-1 is a marker for abnormal distribution of naive/memory T cell subsets in HIV-1 infection. J. Immunol. 191, 2194–2204 (2013).

Article  CAS  PubMed  Google Scholar 

Kulpa, D. A. et al. The immunological synapse: the gateway to the HIV reservoir. Immunol. Rev. 254, 305–325 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Ando, M., Ito, M., Srirat, T., Kondo, T. & Yoshimura, A. Memory T cell, exhaustion, and tumor immunity. Immunol. Med. 43, 1–9 (2020).

Article  PubMed  Google Scholar 

Seidel, J. A., Otsuka, A. & Kabashima, K. Anti-PD-1 and Anti-CTLA-4 therapies in cancer: mechanisms of action, efficacy, and limitations. Front. Oncol. 8, 86 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Li, P. et al. The third generation anti-HER2 chimeric antigen receptor mouse T cells alone or together with anti-PD1 antibody inhibits the growth of mouse breast tumor cells expressing HER2 in vitro and in immune competent mice. Front. Oncol. 10, 1143 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Liu, J. et al. Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma. J. Exp. Med. 216, 656–673 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turnis, M. E., Andrews, L. P. & Vignali, D. A. Inhibitory receptors as targets for cancer immunotherapy. Eur. J. Immunol. 45, 1892–1905 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sawant, D. V. et al. Adaptive plasticity of IL-10(+) and IL-35(+) Treg cells cooperatively promotes tumor T cell exhaustion. Nat. Immunol. 20, 724–735 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kwok, G., Yau, T. C., Chiu, J. W., Tse, E. & Kwong, Y. L. Pembrolizumab (Keytruda). Hum. Vaccin Immunother. 12, 2777–2789 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Robert, C. et al. Pembrolizumab versus ipilimumab in advanced melanoma. N. Engl. J. Med. 372, 2521–2532 (2015).

Article  CAS  PubMed